A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...

A New York-based neurotech startup, Synchron, successfully implanted its brain-computer interface into a blood vessel on the ...

Prince Middleton and Kate Middleton shared their support on X for a new book written by late rugby star and ALS advocate Rob ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...

A patient with a degenerative disease was able to command Amazon's Alexa digital assistant with his mind, the company behind ...

A man with ALS became the first person to control an Amazon Alexa with his thoughts via an implanted brain-computer interface ...

Siplizumab is under clinical development by ITB-Med and currently in Phase I for Amyotrophic Lateral Sclerosis.

Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Amyotrophic Lateral Sclerosis.

The Muscular Dystrophy Association (MDA) is proud to announce a new clinical research grant of $500,000 over three years, awarded to Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital (MGH).

The CEO Soak is on Thursday, Sept. 19 from 1 p.m. – 3 p.m. in St. Petersburg. People can sign up for the cause and help raise funds to beat the disease.

She steered vacationers and business travelers to choice destinations, talked about the best deals, and offered up savvy tips ...

Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.